Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Alteplase in Acute Ischaemic Stroke (ATTEST-2)
NCT02814409Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Dec 2016
- Primary completion
- Aug 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by NHS Greater Glasgow and Clyde. Started Dec 2016; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02814409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814409.